Nanoscale Metal–Organic Frameworks for Cancer Immunotherapy

免疫佐剂 免疫疗法 癌症免疫疗法 医学 肿瘤微环境 癌症 癌症研究 癌症疫苗 光动力疗法 免疫系统 免疫原性细胞死亡 抗原 免疫学 内科学 化学 有机化学
作者
Kaiyuan Ni,Taokun Luo,Geoffrey T. Nash,Wenbin Lin
出处
期刊:Accounts of Chemical Research [American Chemical Society]
卷期号:53 (9): 1739-1748 被引量:218
标识
DOI:10.1021/acs.accounts.0c00313
摘要

Conspectus Cancer immunotherapy, particularly checkpoint blockade immunotherapy (CBI), has revolutionized the treatment of some cancers by reactivating the antitumor immunity of hosts with durable response and manageable toxicity. However, many cancer patients with low tumor antigen exposure and immunosuppressive tumor microenvironments do not respond to CBI. A variety of methods have been investigated to reverse immunosuppressive tumor microenvironments and turn “cold” tumors “hot” with the goal of extending the therapeutic benefits of CBI to a broader population of cancer patients. Immunostimulatory adjuvant treatments, such as cancer vaccines, photodynamic therapy (PDT), radiotherapy (RT), radiotherapy–radiodynamic therapy (RT-RDT), and chemodynamic therapy (CDT), promote antigen presentation and T cell priming and, when used in combination with CBI, reactivate and sustain systemic antitumor immunity. Cancer vaccines directly provide tumor antigens, while immunoadjuvant therapies such as PDT, RT, RT-RDT, and CDT kill cancer cells in an immunogenic fashion to release tumor antigens in situ. Direct administration of tumor antigens or indirect intratumoral immunoadjuvant therapies as in situ cancer vaccines initiate the immuno-oncology cycle for antitumor immune response. With the rapid growth of cancer nanotechnology in the past two decades, a large number of nanoparticle platforms have been studied, and some nanomedicines have been translated into clinical trials. Nanomedicine provides a promising strategy to enhance the efficacy of immunoadjuvant therapies to potentiate cancer immunotherapy. Among these nanoparticle platforms, nanoscale metal–organic frameworks (nMOFs) have emerged as a unique class of porous hybrid nanomaterials with metal cluster secondary building units and organic linkers. With molecular modularity, structural tunability, intrinsic porosity, tunable stability, and biocompatibility, nMOFs are ideally suited for biomedical applications, particularly cancer treatments. In this Account, we present recent breakthroughs in the design of nMOFs as nanocarriers for cancer vaccine delivery and as nanosensitizers for PDT, CDT, RT, and RT-RDT. The versatility of nMOFs allows them to be fine-tuned to effectively load tumor antigens and immunoadjuvants as cancer vaccines and significantly enhance the local antitumor efficacy of PDT, RT, RT-RDT, and CDT via generation of reactive oxygen species (ROS) for in situ cancer vaccination. These nMOF-based treatments are further combined with cancer immunotherapies to elicit systemic antitumor immunity. We discuss novel strategies to enhance light tissue penetration and overcome tumor hypoxia in PDT, to increase energy deposition and ROS diffusion in RT, to combine the advantages of PDT and RT to enable RT-RDT, and to trigger CDT by hijacking aberrant metabolic processes in tumors. Loading nMOFs with small-molecule drugs such as an indoleamine 2,3-dioxygenase inhibitor, the toll-like receptor agonist imiquimod, and biomacromolecules such as CpG oligodeoxynucleotides and anti-CD47 antibody synergizes with nMOF-based radical therapies to enhance their immunotherapeutic effects. Further combination with immune checkpoint inhibitors activates systemic antitumor immune responses and elicits abscopal effects. With structural and compositional tunability, nMOFs are poised to provide a new clinically deployable nanotechnology platform to promote immunostimulatory tumor microenvironments by delivering cancer vaccines, mediating PDT, enhancing RT, enabling RT-RDT, and catalyzing CDT and potentiate cancer immunotherapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
隐形曼青的应助被科研通管家采纳,获得10
刚刚
null的应助被科研通管家采纳,获得10
刚刚
烟花的应助被科研通管家采纳,获得10
1秒前
ghn123456789完成签到,获得积分0
1秒前
diguohu完成签到,获得积分10
1秒前
敏感的飞松完成签到 ,获得积分10
2秒前
Fulcher完成签到 ,获得积分10
2秒前
854fycchjh完成签到,获得积分10
2秒前
天际完成签到,获得积分10
2秒前
no1isme完成签到 ,获得积分10
4秒前
FengQY完成签到 ,获得积分10
4秒前
吴旭东完成签到,获得积分10
5秒前
某某完成签到,获得积分10
6秒前
王12完成签到,获得积分10
7秒前
seemon完成签到 ,获得积分10
7秒前
8秒前
笑对人生完成签到 ,获得积分10
9秒前
9秒前
打打的应助被等待幼荷采纳,获得10
9秒前
mongmong完成签到 ,获得积分10
10秒前
要减肥的湘云完成签到,获得积分10
10秒前
木木完成签到,获得积分10
10秒前
生物科研小白完成签到 ,获得积分10
11秒前
ange完成签到,获得积分10
12秒前
青桔完成签到,获得积分10
13秒前
lz完成签到,获得积分10
13秒前
koi完成签到,获得积分10
13秒前
科研废柴完成签到 ,获得积分10
14秒前
惜缘完成签到 ,获得积分10
14秒前
YY完成签到,获得积分10
14秒前
GraysonG完成签到 ,获得积分10
14秒前
小暴完成签到,获得积分10
15秒前
沈澜完成签到 ,获得积分10
16秒前
你好完成签到 ,获得积分10
17秒前
18秒前
chenyunxia完成签到,获得积分10
18秒前
一心完成签到,获得积分10
19秒前
崔文浩完成签到,获得积分10
19秒前
单身的绮烟完成签到 ,获得积分10
20秒前
飘逸的小天鹅完成签到,获得积分10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159131
求助须知:如何正确求助?哪些是违规求助? 9554607
关于积分的说明 21719828
捐赠科研通 7748795
什么是DOI,文献DOI怎么找? 3427149
关于科研通互助平台的介绍 2552079
邀请新用户注册赠送积分活动 2471428